Meeting Coverage:

American Academy of Ophthalmology

AAO: 2021

Patient-Reported Outcomes With a Presbyopia Eye Drop

Show Description +

Cathleen M. McCabe, MD, reports on the significant improvements in patient-reported outcomes with Vuity (pilocarpine HCl ophthalmic solution 1.25%, Allergan) versus a vehicle in GEMINI 1 and GEMINI 2, two pivotal phase 3 clinical studies evaluating the efficacy, safety, and tolerability of the agent for the treatment of presbyopia.

Posted: 11/14/2021

Keywords:

Presbyopia

Clinical Trials

Patient-Reported Outcomes With a Presbyopia Eye Drop

Cathleen M. McCabe, MD, reports on the significant improvements in patient-reported outcomes with Vuity (pilocarpine HCl ophthalmic solution 1.25%, Allergan) versus a vehicle in GEMINI 1 and GEMINI 2, two pivotal phase 3 clinical studies evaluating the efficacy, safety, and tolerability of the agent for the treatment of presbyopia.

Posted: 11/14/2021

Keywords:

Presbyopia

Clinical Trials

Please log in to leave a comment.